European Neurology
Risk of Recurrent Stroke, Myocardial Infarction and Epilepsy during Long-Term Follow-Up after StrokeViitanen M. · Eriksson S. · Asplund K.Departments of Geriatric Medicine and Internal Medicine, University Hospital, Umeå, Sweden
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: July 11, 1987
Accepted: November 30, 1987
Published online: February 05, 2008
Issue release date: 1988
Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 0
ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)
For additional information: https://www.karger.com/ENE
Abstract
The risk of recurrent stroke, myocardial infarction and epilepsy was analyzed in a population-based cohort of 409 stroke patients (mean age 72 years) observed for 3.5–7 years. As assessed by the life table technique, the proportion of survivors in the cohort was 69 ± 5 % at 1 year and 38 ± 7 % at 5 years. During the first year, the risk for recurrent stroke was 14 ± 4%, and the accumulated risk for stroke recurrence at 5 years was 37 ± 10%. The probability for myocardial infarction was estimated to be 7 ± 3 % at 1 year and 19 ± 8 % at 5 years. The risk of recurrent stroke was enhanced in patients of high age and with a history of cardiac failure (p < 0.05), whereas the risk of myocardial infarction was associated with high age, angina pectoris and diabetes mellitus (p < 0.05). The risk of epilepsy was 3 ± 2% at 1 year and 5 ± 4% at 5 years. The considerable risk of recurrent stroke, myocardial infarction and epilepsy adds to the sequelae of the initial cerebrovascular accident.
© 1988 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: July 11, 1987
Accepted: November 30, 1987
Published online: February 05, 2008
Issue release date: 1988
Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 0
ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)
For additional information: https://www.karger.com/ENE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission